Global /United Kingdom /Healthcare /Medical Devices /CREO
chevron_leftBack
Creo Medical Group PLC logo

Creo Medical Group PLC

CREO
LSE: CREO Delayed
12GBX 1%
0.1634 USD
As of 8 June 2026, Creo Medical Group PLC has a market cap of $65.35M USD, ranking #28604 globally and #655 in the United Kingdom. It ranks #2594 in the Healthcare sector, and #532 in the Medical Devices industry.
Global Rank
28604
Country Rank
655
Sector Rank
2594
Industry Rank
532
Key Stats
Market Cap
$65.35MUSD
48.8M GBP
Enterprise Value
$43.34MUSD
32.5M GBP
Revenue (TTM)
$6.16MUSD
4.6M GBP
EBITDA (TTM)
-$31.07MUSD
-23.3M GBP
Net Income (TTM)
$669.53KUSD
500.0K GBP
Profit Margin
11%
PE Ratio
55.0
PS Ratio
10.6
PB Ratio
0.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Craig Gulliford open_in_new
Employees
129
Founded
2003
Website
creomedical.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
1% -5.9% 1.1% -5% 7.9% 23%

News

Loading...

Markets

Exchange Ticker Price
London Stock Exchange
MIC: XLON
PRIMARY
CREO
ISIN: GB00BZ1BLL44
Shares Out.:
449.14M1 Shares Float: 410.328M2
TV:
SA:
YF:
GF:
BA:
MS:
12 GBX
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Creo Medical Group PLC

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develps CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a microwave ablation device designed for soft tissue ablation; and SpydrBlade Flex, a multi-modal endoscopic scissor-type device. In addition, it provides endotherapy accessories comprising injection needles, haemostatic clips, snares, and forceps, as well as other products for gastroenterology, pulmonology, and urology. Further, the company offers products for diagnostic, therapeutic, and hygiene purposes. Creo Medical Group PLC was founded in 2003 and is headquartered in Chepstow, the United Kingdom.

Similar Companies

Industry: Medical Devices (United Kingdom)
Name
Market Cap diff.
PE
$13.24B
9.88B GBP
20K%
21.8
CTEC
$5.69B
4.25B GBP
9K%
34.0
LIVN
$3.22B
5K%
-
NVCR
$1.38B
2K%
-
$723.56M
540.36M GBP
1K%
55.3
TSTL
$239.08M
178.54M GBP
266%
22.9
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
$173.27B
265K%
25.8
$160.73B
246K%
56.7
$159.07B
243K%
25.6
DHR
$126.55B
194K%
34.7
SYK
$120.69B
185K%
38.3
MDT
$101.9B
156K%
22.2
chevron_leftBack